missing translation for 'onlineSavingsMsg'
Learn More

EBF-2 Rabbit anti-Human, Polyclonal, Novus Biologicals™

Rabbit Polyclonal Antibody

£385.00 - £587.00

Specifications

Antigen EBF-2
Dilution Immunocytochemistry/Immunofluorescence 0.25 to 2 μg/mL
Applications Immunofluorescence
Classification Polyclonal
Conjugate Unconjugated
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18364184
View Documents
Novus Biologicals
NBP3-17358-25UL
25 μg
£385.00
25µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18338455
View Documents
Novus Biologicals
NBP3-17358-100UL
100 μg
£587.00
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

EBF-2 Polyclonal antibody specifically detects EBF-2 in Human samples. It is validated for Immunofluorescence
Specifications

Specifications

EBF-2
Immunofluorescence
Unconjugated
Rabbit
Human
COE2, EBF-2, O/E-3, OE-3
This antibody was developed against Recombinant Protein corresponding to amino acids: PGFLNGSPTGSPYGIMSSSPTVGSSSTSSILPF
Primary
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Immunocytochemistry/Immunofluorescence 0.25 to 2 μg/mL
Polyclonal
Purified
RUO
PBS, pH 7.2, 40% glycerol
64641
IgG
Affinity purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.